Place of oligopeptide H-Met-Glu-His-Phe-Pro-Gly-Pro-OH in the therapy and rehabilitation of patients with ischemic stroke

Cerebrovascular diseases (CVDs) are one of the leading causes of death and disability In Russia: they rank second in the structure of mortality from diseases of the circulatory system and in the overall mortality of the population. Successful treatment of CVD involves an integrated approach to the p...

Full description

Bibliographic Details

Published in:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova Vol. 124; no. 8. Vyp. 2; p. 56
Main Authors:	Spirin, N N, Fedorov, V N, Vdovichenko, V P
Format:	Journal Article
Language:	Russian
Published:	Russia (Federation) 2024
Subjects:	Administration, Intranasal Humans Ischemic Stroke - drug therapy Neuroprotective Agents - administration & dosage Neuroprotective Agents - therapeutic use Oligopeptides - therapeutic use Stroke Rehabilitation - methods cerebrovascular diseases oligopeptide H-Met-Glu-His-Phe-Pro-Gly-Pro-OH ischemic stroke neuroprotectors
ISSN:	1997-7298
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!